A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors

Conditions: Advanced Solid Tumor (Phase 1); Pancreas Adenocarcinoma; Non-small Cell Lung Cancer; Malignant Melanoma (Cutaneous) Interventions: Drug: IMM-6-415 Sponsors: Immuneering Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials